- Home
- PHAR vs REI Comparison
PHAR vs REI Comparison
Compare PHAR & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- REI
- Stock Information
- Founded
- PHAR 1988
- REI 2004
- Country
- PHAR Netherlands
- REI United States
- Employees
- PHAR N/A
- REI N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- REI Oil & Gas Production
- Sector
- PHAR Health Care
- REI Energy
- Exchange
- PHAR Nasdaq
- REI Nasdaq
- Market Cap
- PHAR 527.8M
- REI N/A
- IPO Year
- PHAR N/A
- REI N/A
- Fundamental
- Price
- PHAR $7.08
- REI $1.59
- Analyst Decision
- PHAR Strong Buy
- REI
- Analyst Count
- PHAR 1
- REI 0
- Target Price
- PHAR $37.00
- REI N/A
- AVG Volume (30 Days)
- PHAR 5.5K
- REI 1.1M
- Earning Date
- PHAR 10-24-2024
- REI 10-31-2024
- Dividend Yield
- PHAR N/A
- REI N/A
- EPS Growth
- PHAR N/A
- REI N/A
- EPS
- PHAR N/A
- REI 0.36
- Revenue
- PHAR $277,557,000.00
- REI $369,496,377.00
- Revenue This Year
- PHAR $24.70
- REI $12.45
- Revenue Next Year
- PHAR $12.97
- REI $0.70
- P/E Ratio
- PHAR N/A
- REI $4.38
- Revenue Growth
- PHAR 34.54
- REI 7.61
- 52 Week Low
- PHAR $6.65
- REI $1.25
- 52 Week High
- PHAR $16.71
- REI $2.20
- Technical
- Relative Strength Index (RSI)
- PHAR 40.54
- REI 35.39
- Support Level
- PHAR $7.15
- REI $1.79
- Resistance Level
- PHAR $8.04
- REI $1.91
- Average True Range (ATR)
- PHAR 0.35
- REI 0.07
- MACD
- PHAR -0.05
- REI -0.03
- Stochastic Oscillator
- PHAR 0.00
- REI 7.89
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.